| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Finance > Why Do Mortgage Consultants Work For Their Clients And Not For Lenders? (Courtier Hypothecaire) |
|
Advice You - Why Do Mortgage Consultants Work For Their Clients And Not For Lenders? (Courtier Hypothecaire)
If you are going to submit an application for a mortgage, you will feel that you are in a sort of contest with According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product the lender, since you are on two different sides of the issue. The lender wants the highest interest rate so he ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in can make the most money, and you want the lowest interest rate so you can save the most money. A mortgage consu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tant (courtier hypothecaire) will act as a middle man in these transactions. Is the broker on the side of the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ender or the borrower in this situation? When you hear that the lending institution pays the broker’s commissio d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro , you may think that the broker is going to work for the interests of the lender. This is not what happens. Th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc home loan business is a very competitive business in Canada. Some of the larger mortgage brokers (courtier hyp easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi theque) handle billions of dollars of mortgages each year. LendersLending institutions are interested in workin nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically with brokers so they can increase their loan business as much as possible. The lending institutions pay all o and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the brokers about the same fee. Because of this, brokers (courtier hypoth?caire) are fairly independent, since ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi they are going to make the same commission from any one of the many lenders. The borrowers are pleased that the ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lender pays the fee, and he does not have to. Fierce competition such as this leads lenders to partner with br dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod kers and that a broker can show a borrower’s loan file to 50 lenders without any extra effort by the borrower. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin This is the reason the borrower can be considered a client of the broker (courtier hypoth?caire). A broker wil tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen try to get the best mortgage package for each of his clients. Since a broker will make the same commission fr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel m any lender, his goal will be: •Make sure his clients are happy and will become repeat customers •Make sure ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust is clients are satisfied and will refer him to others Mortgage consultants (courtier hypothecaire) earn their y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products alary by the commissions they are paid. Their primary goal is to serve their clients and build up a reputation . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o that their business will grow based on recommendations. The bottom line is that, even though the lender pays elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the fee, it is the borrower who benefits from this relationship, since the broker has to keep his clients happy tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Public Relations and Real Estate Sales Companies Sales Questions Designed To Work Internet Marketing – Run With A Legitimate Internet Marketing Strategy
|